Endocrinology

Top Story

34% of physicians have been sued: How to best minimize your risk

34% of physicians have been sued: How to best minimize your risk
February 23, 2018
In the Journals

School obesity prevention program did not impact childhood BMI

February 23, 2018
A school intervention program did not have a significant impact on BMI or preventing childhood obesity, according to recently published study results. “Excess…
In the Journals Plus

Despite benefits, intermittent fasting increases risk for hypoglycemia in type 2 diabetes

February 23, 2018
Intermittent fasting increased hypoglycemia among patients with type 2 diabetes who were treated with hypoglycemic medications, according to the results of a study
In the Journals Plus

Earlier type 2 diabetes diagnosis predicts risk for premature CV death

February 23, 2018
An earlier diagnosis of type 2 diabetes, and therefore a longer duration of disease, is associated with increased risk for early all-cause death and earlier…

As widespread flu activity continues, diabetes compounds dangerous risks

February 23, 2018
The most recent reports from the CDC suggest that this season’s influenza outbreak is on course to be one of the worst in recent years, with overall…
More Headlines »
CDR CME CNE CPE

Back to the Future: Clinical Experience with and Access to Lipid-Lowering Agents of the Past, Present, and Future

This activity is supported by educational funding provided by Amgen and Sanofi US and Regeneron Pharmaceuticals.

With each passing year we gain new insight and understanding around the clinical utilization of lipid-lowering…
More »
Video
Meeting News

VIDEO: Public’s reliance on Google costs physicians time with patients

November 1, 2017
More »
Resource Centers
ObesityWeek

ObesityWeek

CNE CME CPE

What You Need to Know About Familial Chylomicronemia Syndrome: Pathophysiology, Diagnosis, Management, and the Patient Perspective

This activity is supported by an educational grant from Akcea Therapeutics™ A Subsidiary of Ionis Pharmaceuticals, Inc.
Endorsed by: The National Lipid Association.

Familial chylomicronemia syndrome (FCS) is a rare genetic disease that leads to severe hypertriglyceridemia and…
More »
Current Issues
View the Current Issue